# Zepp Health Corp: financial statements, quarterly

ZEPP · NYSE · CIK 1720446 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/zepp.md) · [Financials](/companies/zepp/financials.md) · [Filings](/companies/zepp/filings.md) · [Insiders](/companies/zepp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/zepp/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [56.3](/filings/0001564590-18-009509.md) | [210](/filings/0001564590-19-011452.md) | [259](/filings/0001104659-20-050322.md) | [348](/filings/0001104659-21-051700.md) | [230](/filings/0001104659-22-052369.md) | [129](/filings/0001410578-25-000903.md) | [134](/filings/0001104659-26-048127.md) | [91.1](/filings/0001104659-26-048127.md) | [57.0](/filings/0001104659-26-048127.md) |
| Current assets | $m | [199](/filings/0001564590-18-009509.md) | [416](/filings/0001564590-19-011452.md) | [631](/filings/0001104659-20-050322.md) | [740](/filings/0001104659-21-051700.md) | [617](/filings/0001104659-22-052369.md) | [429](/filings/0001104659-23-049064.md) | [317](/filings/0001410578-25-000903.md) | [252](/filings/0001104659-26-048127.md) | [294](/filings/0001104659-26-048127.md) |
| Total assets | $m | [225](/filings/0001564590-18-009509.md) | [474](/filings/0001564590-19-011452.md) | [743](/filings/0001104659-20-050322.md) | [905](/filings/0001104659-21-051700.md) | [955](/filings/0001104659-22-052369.md) | [764](/filings/0001104659-23-049064.md) | [636](/filings/0001410578-25-000903.md) | [529](/filings/0001104659-26-048127.md) | [565](/filings/0001104659-26-048127.md) |
| Current liabilities | $m | [135](/filings/0001564590-18-009509.md) | [202](/filings/0001564590-19-011452.md) | [356](/filings/0001104659-20-050322.md) | [428](/filings/0001104659-21-051700.md) | [338](/filings/0001104659-22-052369.md) | [242](/filings/0001104659-23-049064.md) | [155](/filings/0001410578-25-000903.md) | [195](/filings/0001104659-26-048127.md) | [287](/filings/0001104659-26-048127.md) |
| Total liabilities | $m | [136](/filings/0001564590-18-009509.md) | [211](/filings/0001564590-19-011452.md) | [385](/filings/0001104659-20-050322.md) | [486](/filings/0001104659-21-051700.md) | [495](/filings/0001104659-22-052369.md) | [374](/filings/0001104659-23-049064.md) | [283](/filings/0001410578-25-000903.md) | [276](/filings/0001104659-26-048127.md) | [350](/filings/0001104659-26-048127.md) |
| Long-term debt | $m | not reported | not reported | not reported | [9.2](/filings/0001104659-21-051700.md) | [114](/filings/0001104659-22-052369.md) | [99.2](/filings/0001104659-23-049064.md) | [120](/filings/0001410578-25-000903.md) | [75.2](/filings/0001104659-26-048127.md) | [59.5](/filings/0001104659-26-048127.md) |
| Shareholders' equity | $m | [34.7](/filings/0001564590-18-009509.md) | [263](/filings/0001564590-19-011452.md) | [359](/filings/0001104659-20-050322.md) | [418](/filings/0001104659-21-051700.md) | [458](/filings/0001104659-22-052369.md) | [387](/filings/0001104659-23-049064.md) | [351](/filings/0001410578-25-000903.md) | [252](/filings/0001104659-26-048127.md) | [215](/filings/0001104659-26-048127.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.